返回
Proteomic Profiling and Pathophysiological Implications in Multiple Sclerosis
DOI:10.1212/NXI.0000000000200341.png)
摘要
En
期刊
N
IF:
7.5
论文数:
1.2K
被引数:
6.1K
机构
引用论文
Proteomics reveal biomarkers for diagnosis, disease activity and long-term disability outcomes in multiple sclerosis蛋白质组学揭示多发性硬化诊断,疾病活动和长期残疾结果的生物标志物
NATURE COMMUNICATIONS
IF15.7
Plasma proteomic profiles of UK Biobank participants with multiple sclerosis患有多发性硬化症的英国生物银行参与者的血浆蛋白质组学概况
Proteomics Reveals Age as Major Modifier of Inflammatory CSF Signatures in Multiple Sclerosis蛋白质组学揭示年龄是多发性硬化症炎性CSF特征的主要修饰因子
The prevalence of MS in the United States A population-based estimate using health claims data使用健康索赔数据对美国MS的患病率进行基于人群的估计
NEUROLOGY
IF8.5
Blood GFAP as an emerging biomarker in brain and spinal cord disorders
NATURE REVIEWS NEUROLOGY
IF33.1
没有更多内容

